Elutia price target lowered to $10 from $11 at Cantor Fitzgerald

Cantor Fitzgerald lowered the firm’s price target on Elutia to $10 from $11 and keeps an Overweight rating on the shares following the Q2 results. The 2024 story continues to center around the commercial launch of EluPro, as the company is methodically ramping its sales force as it now has 26 representatives on the EluPro team and says it has sufficient manufacturing capacity to scale EluPro, as the VAC approval process remains the rate-limiting step to driving adoption in the near-term, the analyst tells investors in a research note.